Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101792438A details a copper-catalyzed decarboxylative coupling for high-purity triazole intermediates, offering cost-effective manufacturing solutions.
Patent CN110117237B reveals a mild nickel-catalyzed cyanation method for aromatic nitriles. This technology offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN110683926B reveals a robust Pd-catalyzed method for direct C-O coupling, offering high yields and broad substrate scope for reliable pharmaceutical intermediate manufacturing.
Patent CN107602452B reveals a one-pot copper-catalyzed method for 3-acyl pyridines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel Mo/Cu co-catalyzed method for high-purity triazole intermediates. Reduces steps and costs for API manufacturing with mild conditions.
Novel copper-catalyzed route for high-purity quinazolinone intermediates. Enhanced yield and fluorescence sensing applications for industrial procurement and supply chain stability.
Patent CN110467555B reveals a chiral phosphoric acid catalyzed route for high-purity axial chiral aryl indoles, offering cost-effective API intermediate manufacturing.
Patent CN112898192B reveals a safe, one-pot carbonylation route for N-acyl indoles using solid CO sources, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114195711B reveals efficient Pd-catalyzed carbonylation. Delivers high-purity quinoline-4(1H)-one with substantial cost reduction and supply chain reliability.
Novel nickel-catalyzed carbonylation method for indole synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Metal-free heating method for quinoline intermediates. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed carbonylation method offers high yields and broad substrate scope for cost-effective API intermediate manufacturing.
Patent CN113845481A details a copper-catalyzed route to pyridazinone intermediates, offering safer alternatives to hydrazine for reliable pharmaceutical manufacturing.
Patent CN104447440B reveals Mn-catalyzed asymmetric oxidation. High purity, green process, supply chain reliability for pharma intermediates.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Cost-effective, scalable route for API intermediates without heavy metals.
This patent details a copper-catalyzed synthesis for 1-naphthylamine derivatives offering high yields. It enables cost reduction and scalable manufacturing for reliable pharmaceutical intermediate suppliers globally.
Patent CN113045489A reveals a novel Pd-catalyzed aminocarbonylation route for high-purity API intermediates, offering significant cost reduction and scalable manufacturing.
Novel one-pot synthesis for 9H-pyrimido[4,5-b]indoles using copper catalysis. Reduces steps and cost for pharmaceutical intermediates.
Patent CN114539198B reveals a novel Pd-catalyzed route for chroman amides, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113307778A reveals a novel Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and scalable production.